葛兰素史克Glaxosmithkline（GSK）2025年负责任商业报告「LSE」（英文版）（15页）.pdf

1、Responsible businessStrategic reportCorporate governanceFinancial statementsInvestor informationGSK Annual Report 202547Lais is a scientist with our global health team,working mostly on infectious diseases that affect low-and middle-income countries.“I get to apply my curiosity to the early stages o

2、f projects tomake an impact at improving global health,”says Lais.“My purpose is to be part of a team that will help people who need it most.”Watch Lais story on Our approachBeing a responsible business is vital to our strategy and long-term success.It helps us build and sustain trust with ourstakeh

3、olders,reduce risk,support our people to thrive and deliver positive health impact at scale.To deliver on our purpose,we must consider our impacts,risks and opportunities across everything we do,in our business and value chain.We focus on six areas to help usaddress whats most material to our busine

4、ss and most important to our stakeholders:Access to healthcare Global health and health security Environment Inclusion Ethical standards Product governance To sustain trust,we must be responsive to the environment we operate in,and to our key stakeholders changing expectations.This means we continue

5、 to review and evolve what we do in all six focus areas and monitor our external environment and strategic priorities to make sure were focusing on the right areas.MaterialityWe regularly undertake materiality assessments to assess the key issues that matter most to our business and stakeholders.The

6、 results inform our approach to reporting and the metrics we include in our Responsible Business Performance Rating(see below).In 2024,we carried out a double materiality assessment toprepare for reporting under the Corporate Sustainability Reporting Directive(CSRD),following guidance from European